Green Synthesis of Copper Manganese Oxide Nanoparticles from Ginkgo Biloba Extract and Study of their Activity on PC3 Cancer Cell Line

Heba Jassim Younis, Mustafa Hammadi and Rulla Sabah

References:

1. J.-Y. Zhang, L.-J. Zhao, and Y.-T. Wang, “Synthesis and clinical application of small-molecule drugs approved to treat prostatic cancer,” Eur. J. Med. Chem., vol. 262, p. 115925, 2023.
2. G. Joshi et al., “Growth factors mediated cell signalling in prostate cancer progression: Implications in discovery of anti-prostate cancer agents,” Chem. Biol. Interact., vol. 240, pp. 120–133, 2015.
3. F. A. Fisusi and E. O. Akala, “Drug combinations in breast cancer therapy,” Pharm. Nanotechnol., vol. 7, no. 1, pp. 3–23, 2019.
4. C. Taylor and A. Kirby, “Cardiac side-effects from breast cancer radiotherapy,” Clin. Oncol., vol. 27, no. 11, pp. 621–629, 2015.
5. Z. Zhang et al., “The potential of marine-derived piperazine alkaloids: Sources, structures and bioactivities,” Eur. J. Med. Chem., vol. 265, p. 116081, 2024.
6. T. Youshikawa, Y. Naito, and M. Kondo, “Ginkgo Biloba leaf extract–review of biological actions,” Antioxid. Redox Signal., vol. 4, pp. 469–480, 1999.
7. T. K. Mohanta, Y. Tamboli, and P. Zubaidha, “Phytochemical and medicinal importance of Ginkgo biloba L.,” Nat. Prod. Res., vol. 28, no. 10, pp. 746–752, 2014.
8. W. Zuo et al., “Advances in the studies of Ginkgo biloba leaves extract on aging-related diseases,” Aging Dis., vol. 8, no. 6, pp. 812–823, 2017.
9. E. Koch, “Inhibition of platelet activating factor (PAF)-induced aggregation of human thrombocytes by ginkgolides: considerations on possible bleeding complications after oral intake of Ginkgo biloba extracts,” Phytomedicine, vol. 12, no. 1–2, pp. 10–16, 2005.
10. B. Avula et al., “Identification of Ginkgo biloba supplements adulteration using HPTLC and UHPLC-DAD-QTOF-MS,” Anal. Bioanal. Chem., vol. 407, pp. 7733–7746, 2015.
11. H. S. Ahmed, M. Hammadi, and W. Majeed, “Green Synthesis of CuCr₂O₄Nano Composite from Rosemary Extract and Evaluation of its Anti-Breast Cancer Properties,” J. Nanostruct., vol. 14, no. 4, pp. 1183–1190, 2024.
12. M. Salah, M. Hammadi, and E. H. Hummadi, “Anticancer activity and cytotoxicity of ZnS nanoparticles on MCF-7 human breast cancer cells,” Biochem. Cell. Arch., vol. 21, no. 1, 2021.
13. W. M. Salih et al., “Green synthesis of (CeO₂)-(CuO) nanocomposite, analytical study, and investigation of their anticancer activity against Saos-2 osteosarcoma cell lines,” Inorg. Chem. Commun., vol. 159, p. 111730, 2024.
14. K. Xiao et al., “LHRH-targeted redox-responsive crosslinked micelles impart selective drug delivery and effective chemotherapy in triple-negative breast cancer,” Adv. Healthc. Mater., vol. 10, no. 3, p. 2001196, 2021.
15. D. Medina-Cruz et al., “Bimetallic nanoparticles for biomedical applications: A review,” in Racing for the Surface: Antimicrobial and Interface Tissue Engineering, 2020, pp. 397–434.
16. H. Li et al., “Modifying electrical and magnetic properties of SWCNTs by decorating with iron oxide nanoparticles,” J. Nanosci. Nanotechnol., vol. 20, no. 4, pp. 2611–2616, 2020.
17. Z. He, Z. Zhang, and S. Bi, “Nanoparticles for organic electronics applications,” Mater. Res. Express, vol. 7, no. 1, p. 012004, 2020.
18. N. O. Alafaleq et al., “Biogenic synthesis of Cu-Mn bimetallic nanoparticles using pumpkin seeds extract and their characterization and anticancer efficacy,” Nanomaterials, vol. 13, no. 7, p. 1201, 2023.
19. K. A. Elsayed et al., “Fabrication of ZnO-Ag bimetallic nanoparticles by laser ablation for anticancer activity,” Alex. Eng. J., vol. 61, no. 2, pp. 1449–1457, 2022.
20. Y. Cao et al., “Green synthesis of bimetallic ZnO–CuO nanoparticles and their cytotoxicity properties,” Sci. Rep., vol. 11, no. 1, p. 23479, 2021.
21. A. Eskandari and K. Suntharalingam, “A ROS-generating, CSC-potent Mn(II) complex and its encapsulation into polymeric nanoparticles,” Chem. Sci., vol. 10, no. 33, pp. 7792–7800, 2019.
22. H. S. Ahmed, D. N. J. Hussien, and D. F. M. Yusoff, “Synthesis, characterization, and antibacterial activity of some new metal complexes containing semicarbazide,” Int. J. Appl. Sci., vol. 1, no. 1, pp. 36–49, 2024.
23. T. Mehdizadeh, A. Zamani, and S. M. A. Froushani, “Preparation of Cu nanoparticles fixed on cellulosic walnut shell and its antibacterial, antioxidant, and anticancer effects,” Heliyon, vol. 6, no. 3, 2020.
24. K. Skłodowski et al., “Metallic nanosystems in antimicrobial strategies with high activity and biocompatibility,” Int. J. Mol. Sci., vol. 24, no. 3, p. 2104, 2023.
25. H. Y. Jassim and M. Hammadi, “Synthesis, green chemistry method characterization of CuFe₅O₈ nanocomposite and assessment of its prostate cancer-preventive effects,” 2024.
26. M. Hammadi, E. H. Hummadi, and R. Sabah, “Synthesis of CuS nanoparticle and investigation of their anticancer activity against a human breast cancer cell line,” J. Pharm. Negat. Results, vol. 13, no. 2, 2022.
27. P. Wayne, Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, 2011.
28. A. Carrapiço et al., “Biosynthesis of metal and metal oxide nanoparticles using microbial cultures: mechanisms, antimicrobial activity and applications to cultural heritage,” Microorganisms, vol. 11, no. 2, p. 378, 2023.
29. M. R. Shaik et al., “Mn₃O₄ nanoparticles: Synthesis, characterization and their antimicrobial and anticancer activity,” Saudi J. Biol. Sci., vol. 28, no. 2, pp. 1196–1202, 2021.
30. M. Beley, L. Padel, and J. C. B., “Etudes et propriétés des composés CuₓMn₃₋ₓO₄ (avec x = 1, 0; 1, 2 et 1, 4),” 1978.
31. A. A. K. Rikabi et al., “Optimization of ecofriendly L-Fe/Ni nanoparticles prepared using black tea extract for removal of tetracycline from groundwater,” South Afr. J. Chem. Eng., vol. 50, pp. 89–99, 2024.
32. M. Nasrollahzadeh, M. Sajjadi, and S. M. Sajadi, “Biosynthesis of Cu nanoparticles supported on MnO₂ using Centella asiatica extract for catalytic reduction,” Chin. J. Catal., vol. 39, no. 1, pp. 109–117, 2018.
33. R. A. Salman, M. W. M. Alzubaidy, and A. T. Tawfeeq, “Effect of Mirabilis jalapa fortified with nano-quercetin to accelerate wound healing in vivo,” J. Glob. Innov. Agric. Sci., vol. 12, pp. 717–723, 2024.
34. R. Foldbjerg et al., “PVP-coated silver nanoparticles and silver ions induce ROS, apoptosis and necrosis in THP-1 monocytes,” Toxicol. Lett., vol. 190, no. 2, pp. 156–162, 2009.
35. N. Asare et al., “Cytotoxic and genotoxic effects of silver nanoparticles in testicular cells,” Toxicology, vol. 291, no. 1–3, pp. 65–72, 2012.
36. R. H. Whitaker and W. J. Placzek, “Regulating the BCL2 family to improve sensitivity to microtubule targeting agents,” Cells, vol. 8, no. 4, p. 346, 2019.
37. R. Pati et al., “Zinc-oxide nanoparticles exhibit genotoxic, clastogenic, and cytotoxic effects via oxidative stress,” Toxicol. Sci., vol. 150, no. 2, pp. 454–472, 2016.
38. B. Hamed et al., “A comprehensive investigation using laser ablation method for analyzing nanocomposite anticancer properties,” BioNanoScience, vol. 15, no. 1, p. 96, 2025.